| 1 | [SID160671893] | Active | IC50 | 0.09 | Inhibition of NOD-1 mediated NFkappaB activation in HEK293T cells assessed as inhibition of gamma-tri-DAP-induced luciferase activity after 14 hrs by reporter gene assay [AID655843, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 160671893 | | CID | 1088439 | | Outcome | Active | | IC50 | 0.09 [uM] | | BioAssay | Inhibition of NOD-1 mediated NFkappaB activation in HEK293T cells assessed as inhibition of gamma-tri-DAP-induced luciferase activity after 14 hrs by reporter gene assay | | AID | 655843 | | BioAssay type | Literature | | Target | | | PubMed | 22003428 | | Data Table |  |
|
| 2 | [SID85256232] | Active | IC50 | 0.094 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Active | | IC50 | 0.094 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 3 | [SID85256232] | Active | IC50 | 0.094 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Active | | IC50 | 0.094 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 4 | [SID85248349] | Active | IC50 | 0.485 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 0.485 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 5 | [SID85248349] | Active | IC50 | 0.485 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 0.485 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 6 | [SID85248349] | Active | IC50 | 1.077 | SAR analysis of NF-kB dependent luciferase using DAP as an inducer [AID2264, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 1.077 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using DAP as an inducer | | AID | 2264 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 7 | [SID85248349] | Active | IC50 | 1.077 | SAR analysis of NF-kB dependent luciferase using DAP as an inducer [AID2264, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 1.077 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using DAP as an inducer | | AID | 2264 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 8 | [SID85248349] | Active | IC50 | 1.46 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells [AID2250, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 1.46 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells | | AID | 2250 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 9 | [SID85248349] | Active | IC50 | 1.46 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells [AID2250, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 1.46 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells | | AID | 2250 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 10 | [SID85248349] | Active | IC50 | 1.46 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells [AID2250, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Active | | IC50 | 1.46 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells | | AID | 2250 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 11 | [SID85256232] | Active | IC50 | 19.7 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Active | | IC50 | 19.7 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 12 | [SID85256232] | Active | IC50 | 19.7 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Active | | IC50 | 19.7 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 13 | [SID85256232] | Active | IC50 | 19.7 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Active | | IC50 | 19.7 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 14 | [SID160671893] | Active | IC50 | 19.9 | Inhibition of NOD-2 mediated NFkappaB activation in HEK293T cells assessed as inhibition of MDP-induced luciferase activity after 14 hrs by reporter gene assay [AID655844, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 160671893 | | CID | 1088439 | | Outcome | Active | | IC50 | 19.9 [uM] | | BioAssay | Inhibition of NOD-2 mediated NFkappaB activation in HEK293T cells assessed as inhibition of MDP-induced luciferase activity after 14 hrs by reporter gene assay | | AID | 655844 | | BioAssay type | Literature | | Target | | | PubMed | 22003428 | | Data Table |  |
|
| 15 | [SID99495605] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 17 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 18 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 19 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 20 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 21 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 22 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 23 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 24 | [SID99495605] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 25 | [SID160671893] | Unspecified | IC50 | 20 | Inhibition of TNFalpha-induced NFkappaB activation in HEK293T cells after 14 hrs by luciferase reporter gene assay [AID655845, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 160671893 | | CID | 1088439 | | Outcome | Unspecified | | IC50 | 20 [uM] | | BioAssay | Inhibition of TNFalpha-induced NFkappaB activation in HEK293T cells after 14 hrs by luciferase reporter gene assay | | AID | 655845 | | BioAssay type | Literature | | Target | | | PubMed | 22003428 | | Data Table |  |
|
| 26 | [SID160671893] | Unspecified | | | Cytotoxicity against HEK293T cells at 20 uM by alamar blue assay [AID655846, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 160671893 | | CID | 1088439 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against HEK293T cells at 20 uM by alamar blue assay | | AID | 655846 | | BioAssay type | Literature | | Target | | | PubMed | 22003428 | | Data Table |  |
|
| 27 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. [AID2260, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. | | AID | 2260 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 28 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. [AID2260, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. | | AID | 2260 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 29 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. [AID2260, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells. | | AID | 2260 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 30 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. [AID2245, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. | | AID | 2245 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 31 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. [AID2245, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. | | AID | 2245 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 32 | [SID85248349] | Inactive | IC50 | 5 | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. [AID2245, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 5 [uM] | | BioAssay | SAR analysis of tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells. | | AID | 2245 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 33 | [SID85248349] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 34 | [SID85248349] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 35 | [SID85256232] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 36 | [SID85256232] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 37 | [SID85248349] | Inactive | IC50 | 20 | SAR analysis of compounds that are cytotoxic to HEK293 revised [AID2335, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that are cytotoxic to HEK293 revised | | AID | 2335 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID85256232] | Inactive | IC50 | 20 | SAR analysis of compounds that are cytotoxic to HEK293 revised [AID2335, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85256232 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that are cytotoxic to HEK293 revised | | AID | 2335 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID85248349] | Inactive | IC50 | 25 | SAR analysis of NF-kB dependent luciferase using Doxorucibin as an inducer [AID2255, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using Doxorucibin as an inducer | | AID | 2255 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 40 | [SID85248349] | Inactive | IC50 | 25 | SAR analysis of NF-kB dependent luciferase using Doxorucibin as an inducer [AID2255, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using Doxorucibin as an inducer | | AID | 2255 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 41 | [SID85248349] | Inactive | IC50 | 25 | SAR analysis of NF-kB dependent luciferase using PMA/Ionomycin as an inducer [AID2261, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using PMA/Ionomycin as an inducer | | AID | 2261 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 42 | [SID85248349] | Inactive | IC50 | 25 | SAR analysis of NF-kB dependent luciferase using PMA/Ionomycin as an inducer [AID2261, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85248349 | | CID | 1088439 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kB dependent luciferase using PMA/Ionomycin as an inducer | | AID | 2261 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 43 | [SID99495605] | Inactive | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 44 | [SID99495605] | Inactive | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 45 | [SID99495605] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 46 | [SID99495605] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 47 | [SID99495605] | Inactive | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 48 | [SID99495605] | Inactive | | | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay [AID588489, Type: screening] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay | | AID | 588489 | | BioAssay type | screening | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 49 | [SID99495605] | Inactive | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 50 | [SID99495605] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99495605 | | CID | 1088439 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|